Escoffre-Barbe Martine, Amiot Laurence, Beaucournu Pascale, Jego Patrick, Grulois Isabelle, Grosbois Bernard, Bernard Marc, Fest Thierry, Lamy Thierry, Fardel Olivier
Service d'Hématologie Clinique, Centre Hospitalier et Universitaire, rue Henri Le Guilloux, 35033 Rennes, France.
Am J Hematol. 2006 Jul;81(7):554-6. doi: 10.1002/ajh.20592.
Laboratory detection of spontaneous growth of colony-forming unit-megacaryocytes (CFU-MK), allowing us to distinguish essential thrombocythemia (ET) from reactive thrombocytosis, is therefore useful for the diagnostic of this myeloproliferative disorder. Whether CFU-MK assays allow us to discriminate at least partly between ET and other myeloproliferative disorders such as polycythemia vera (PV) remains, however, to be established. To gain insights about this point, we have performed CFU-MK cultures from bone marrow cells of patients diagnosed with ET (n = 42) or PV (n = 50) using a standardized collagen-based serum-free method. Spontaneous growth of CFU-MK was similarly detected in both 40/42 patients with ET and 47/50 patients with PV. These data suggest clearly that the CFU-MK assay is useful to detect not only ET, but also PV, but fails to discriminate, even partly, between these two myeloproliferative disorders.
